Status:
COMPLETED
AMS Evaluation Study
Lead Sponsor:
GE Healthcare
Conditions:
Patient Monitoring
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A study to evaluate the operational and functional features of the Ambulatory Monitor Solution (AMS) as well as the ease of use of the system.
Detailed Description
The study is going to be conducted to collect feedback from the users about operation of AMS collect parameter raw data from patients in hospital ward setting using the investigational system for use ...
Eligibility Criteria
Inclusion
- Male or female aged 18 years or older (≥18 years);
- Able and willing to provide written informed consent independently.
Exclusion
- Have previously participated in this study (no subject may participate more than once);
- Have an implantable pacemaker;
- Diagnosed with infection requiring isolation; OR
- Known to be pregnant and/or breast feeding;
Key Trial Info
Start Date :
February 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 14 2021
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04472208
Start Date
February 26 2021
End Date
October 14 2021
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chelsea and Westminster Hospital
London, United Kingdom, SW10 9NH